Citigroup’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,165
| Closed | -$9.66K | – | 4958 |
|
|
2024
Q4 | $9.66K | Sell |
5,165
-11,962
| -70% | -$22.4K | ﹤0.01% | 4528 |
|
|
2024
Q3 | $13.3K | Buy |
17,127
+11,962
| +232% | +$9.29K | ﹤0.01% | 4454 |
|
|
2024
Q2 | $3.87K | Hold |
5,165
| – | – | ﹤0.01% | 4526 |
|
|
2024
Q1 | $5.48K | Hold |
5,165
| – | – | ﹤0.01% | 4539 |
|
|
2023
Q4 | $5.42K | Hold |
5,165
| – | – | ﹤0.01% | 4547 |
|
|
2023
Q3 | $5.79K | Hold |
5,165
| – | – | ﹤0.01% | 3958 |
|
|
2023
Q2 | $7.77K | Hold |
5,165
| – | – | ﹤0.01% | 4413 |
|
|
2023
Q1 | $8.06K | Hold |
5,165
| – | – | ﹤0.01% | 4152 |
|
|
2022
Q4 | $3.29K | Sell |
5,165
-391
| -7% | -$249 | ﹤0.01% | 4371 |
|
|
2022
Q3 | $7K | Sell |
5,556
-305
| -5% | -$384 | ﹤0.01% | 4359 |
|
|
2022
Q2 | $13K | Sell |
5,861
-2,851
| -33% | -$6.32K | ﹤0.01% | 4521 |
|
|
2022
Q1 | $54K | Sell |
8,712
-7,729
| -47% | -$47.9K | ﹤0.01% | 3996 |
|
|
2021
Q4 | $207K | Sell |
16,441
-39,369
| -71% | -$496K | ﹤0.01% | 3591 |
|
|
2021
Q3 | $5.12M | Sell |
55,810
-1,219
| -2% | -$112K | ﹤0.01% | 1300 |
|
|
2021
Q2 | $3.02M | Sell |
57,029
-9,534
| -14% | -$505K | ﹤0.01% | 1795 |
|
|
2021
Q1 | $2.4M | Buy |
66,563
+62,323
| +1,470% | +$2.25M | ﹤0.01% | 1834 |
|
|
2020
Q4 | $118K | Buy |
4,240
+3,331
| +366% | +$92.7K | ﹤0.01% | 3572 |
|
|
2020
Q3 | $45K | Sell |
909
-13,226
| -94% | -$655K | ﹤0.01% | 3546 |
|
|
2020
Q2 | $654K | Buy |
14,135
+10,665
| +307% | +$493K | ﹤0.01% | 2385 |
|
|
2020
Q1 | $158K | Buy |
3,470
+1,157
| +50% | +$52.7K | ﹤0.01% | 2996 |
|
|
2019
Q4 | $130K | Buy |
2,313
+2,170
| +1,517% | +$122K | ﹤0.01% | 3368 |
|
|
2019
Q3 | $4K | Sell |
143
-662
| -82% | -$18.5K | ﹤0.01% | 4847 |
|
|
2019
Q2 | $34K | Buy |
+805
| New | +$34K | ﹤0.01% | 4332 |
|